RESUMEN
Pathogenic variants in the PCDH19 gene are associated with epilepsy, intellectual disability (ID) and behavioural disturbances. Only heterozygous females and mosaic males are affected, likely due to a disease mechanism named cellular interference. Until now, only four affected mosaic male patients have been described in literature. Here, we report five additional male patients, of which four are older than the oldest patient reported so far. All reported patients were selected for genetic testing because of developmental delay and/or epilepsy. Custom-targeted next generation sequencing gene panels for epilepsy genes were used. Clinical data were collected from medical records. All patients were mosaic in blood for likely pathogenic variants in the PCDH19 gene. In most, clinical features were very similar to the female phenotype, with normal development before seizure onset, which occurred between 5 and 10 months of age, clustering of seizures and sensitivity to fever. Four out of five patients had mild to severe ID and behavioural problems. We reaffirm the similarity between male and female PCDH19-related phenotypes, now also in a later phase of the disorder (ages 10-14 years).
Asunto(s)
Cadherinas/genética , Epilepsia/genética , Predisposición Genética a la Enfermedad , Discapacidad Intelectual/genética , Mutación/genética , Femenino , Heterocigoto , Secuenciación de Nucleótidos de Alto Rendimiento/métodos , Humanos , Masculino , Protocadherinas , Convulsiones/complicaciones , Factores SexualesRESUMEN
DOCK3 encodes the dedicator of cytokinesis 3 protein, a member of the DOCK180 family of proteins that are characterized by guanine-nucleotide exchange factor activity. DOCK3 is expressed exclusively in the central nervous system and plays an important role in axonal outgrowth and cytoskeleton reorganization. Dock3 knockout mice exhibit motor deficiencies with abnormal ataxic gait and impaired learning. We report 2 siblings with biallelic loss-of-function variants in DOCK3. Diagnostic whole-exome sequencing (WES) and chromosomal microarray were performed on a proband with severe developmental disability, hypotonia, and ataxic gait. Testing was also performed on the proband's similarly affected brother. A paternally inherited 458 kb deletion in chromosomal region 3p21.2 disrupting the DOCK3 gene was identified in both affected siblings. WES identified a nonsense variant c.382C>G (p.Gln128*) in the DOCK3 gene (NM_004947) on the maternal allele in both siblings. Common features in both affected individuals include severe developmental disability, ataxic gait, and severe hypotonia, which recapitulates the Dock3 knockout mouse phenotype. We show that complete DOCK3 deficiency in humans leads to developmental disability with significant hypotonia and gait ataxia, probably due to abnormal axonal development.
Asunto(s)
Ataxia/genética , Proteínas Portadoras/genética , Factores de Intercambio de Guanina Nucleótido/genética , Discapacidad Intelectual/genética , Hipotonía Muscular/genética , Proteínas del Tejido Nervioso/genética , Animales , Ataxia/fisiopatología , Niño , Exoma/genética , Femenino , Humanos , Discapacidad Intelectual/fisiopatología , Masculino , Ratones , Ratones Noqueados , Hipotonía Muscular/fisiopatología , Fenotipo , HermanosRESUMEN
THOC6 is a part of the THO complex, which is involved in coordinating mRNA processing with export. The THO complex interacts with additional components to form the larger TREX complex (transcription export complex). Previously, a homozygous missense mutation in THOC6 in the Hutterite population was reported in association with syndromic intellectual disability. Using exome sequencing, we identified three unrelated patients with bi-allelic mutations in THOC6 associated with intellectual disability and additional clinical features. Two of the patients were compound heterozygous for a stop and a missense mutation, and the third was homozygous for a missense mutation; the missense mutations were predicted to be pathogenic by in silico analysis and modeling. Clinical features of the three newly identified patients and those previously reported are reviewed; intellectual disability is moderate to severe, and malformations are variable including renal and heart defects, cleft palate, microcephaly, and corpus callosum dysgenesis. Facial features are variable and include tall forehead, short upslanting palpebral fissures +/- deep set eyes, and a long nose with overhanging columella. These subtle facial features render the diagnosis difficult to make in isolation with certainty. Our results expand the mutational and clinical spectrum of this rare disease, confirm that THOC6 is an intellectual disability causing gene, while providing insight into the importance of the THO complex in neurodevelopment.
Asunto(s)
Predisposición Genética a la Enfermedad/genética , Discapacidad Intelectual/genética , Mutación Missense , Proteínas de Unión al ARN/genética , Adolescente , Niño , Exoma/genética , Femenino , Genes Recesivos , Genotipo , Humanos , Discapacidad Intelectual/patología , Masculino , Modelos Moleculares , Fenotipo , Dominios Proteicos , Proteínas de Unión al ARN/química , Análisis de Secuencia de ADN/métodos , Índice de Severidad de la Enfermedad , SíndromeRESUMEN
Coxiella burnetii causes significant reproduction losses in livestock and the disease Q fever in humans. Transmission of C. burnetii is facilitated by the stability of the bacterium in the environment and the susceptibility of a variety of host species to infection. Consequently, inter-species transmission occurs frequently through either direct or indirect contact. Wildlife may represent reservoirs of C. burnetii and could therefore be a source of infection for domestic animals. Understanding the prevalence of C. burnetii infections at the wildlife-livestock interface is important for disease control. This study aimed to investigate the extent of C. burnetii exposure in wild deer in eastern Australia. Serum samples were obtained from 413 wild deer from seven regions in four eastern Australian states from 2017 to 2020. Antibodies were detected using a commercial Q fever antibody kit validated for ruminants. Seroprevalence of C. burnetii antibodies in deer was determined and true prevalence estimated, for each region. The overall seroprevalence of C. burnetii antibodies in wild deer was 3.4% (14 seropositive of 413 deer sampled) with true prevalence estimated to be 4.3% (95% credible interval: 0.6%, 10.9%). Seropositive deer were identified only in Queensland (7/108 seropositive) and northern New South Wales (7/120 seropositive). This geospatial distribution is consistent with seropositivity in other animal species and indicative of the level of C. burnetii in the environment. The low seroprevalence suggests that wild deer are unlikely to be a major reservoir species for C. burnetii in eastern Australia but may still be implicated in inter-species transmission cycles.
Asunto(s)
Coxiella burnetii , Ciervos , Fiebre Q , Humanos , Animales , Animales Salvajes , Fiebre Q/epidemiología , Fiebre Q/veterinaria , Ciervos/microbiología , Estudios Seroepidemiológicos , Australia , Anticuerpos Antibacterianos , GanadoRESUMEN
Lipid droplets (LDs) are increasingly recognized as critical organelles in signalling events, transient protein sequestration and inter-organelle interactions. However, the role LDs play in antiviral innate immune pathways remains unknown. Here we demonstrate that induction of LDs occurs as early as 2 h post-viral infection, is transient and returns to basal levels by 72 h. This phenomenon occurs following viral infections, both in vitro and in vivo. Virally driven in vitro LD induction is type-I interferon (IFN) independent, and dependent on Epidermal Growth Factor Receptor (EGFR) engagement, offering an alternate mechanism of LD induction in comparison to our traditional understanding of their biogenesis. Additionally, LD induction corresponds with enhanced cellular type-I and -III IFN production in infected cells, with enhanced LD accumulation decreasing viral replication of both Herpes Simplex virus 1 (HSV-1) and Zika virus (ZIKV). Here, we demonstrate, that LDs play vital roles in facilitating the magnitude of the early antiviral immune response specifically through the enhanced modulation of IFN following viral infection, and control of viral replication. By identifying LDs as a critical signalling organelle, this data represents a paradigm shift in our understanding of the molecular mechanisms which coordinate an effective antiviral response.
Asunto(s)
Interferones/inmunología , Gotas Lipídicas/inmunología , Virosis/inmunología , Animales , Receptores ErbB/antagonistas & inhibidores , Receptores ErbB/metabolismo , Herpesvirus Humano 1/fisiología , Humanos , Inmunidad Innata , Interferones/genética , Interferones/metabolismo , Gotas Lipídicas/metabolismo , Ratones , Ácidos Nucleicos/metabolismo , Replicación Viral/efectos de los fármacos , Virus Zika/fisiologíaRESUMEN
The role of interferon and interferon stimulated genes (ISG) in limiting bacterial infection is controversial, and the role of individual ISGs in the control of the bacterial life-cycle is limited. Viperin, is a broad acting anti-viral ISGs, which restricts multiple viral pathogens with diverse mechanisms. Viperin is upregulated early in some bacterial infections, and using the intracellular bacterial pathogen, S. flexneri, we have shown for the first time that viperin inhibits the intracellular bacterial life cycle. S. flexneri replication in cultured cells induced a predominantly type I interferon response, with an early increase in viperin expression. Ectopic expression of viperin limited S. flexneri cellular numbers by as much as 80% at 5hrs post invasion, with similar results also obtained for the intracellular pathogen, Listeria monocytogenes. Analysis of viperins functional domains required for anti-bacterial activity revealed the importance of both viperin's N-terminal, and its radical SAM enzymatic function. Live imaging of S. flexneri revealed impeded entry into viperin expressing cells, which corresponded to a loss of cellular cholesterol. This data further defines viperin's multi-functional role, to include the ability to limit intracellular bacteria; and highlights the role of ISGs and the type I IFN response in the control of bacterial pathogens.
Asunto(s)
Interferones/metabolismo , Proteínas/genética , Shigella flexneri/fisiología , Activación Transcripcional , Línea Celular , Colesterol/metabolismo , Regulación de la Expresión Génica , Humanos , Oxidorreductasas actuantes sobre Donantes de Grupo CH-CHRESUMEN
OBJECTIVE: Characterisation of a complete genome sequence of an Australian strain of canid alphaherpesvirus 1 (CHV-1) and its phylogenetic relationship with other varicellovirus species. METHODS: Standard pathology and PCR methods were used to initially detect herpesvirus in hepatic tissue from an infected 4-week-old Labrador Retriever puppy. The complete CHV-1 genome was sequenced using next-generation sequencing technology followed by de novo and reference assembly, and genome annotation. RESULTS: The CHV-1 genome was 125 kbp in length and contained 74 predicted open reading frames encoding functional proteins, all of which have counterparts in other alphaherpesviruses. Phylogenetic analysis using the DNA polymerase gene revealed that the newly sequenced CHV-1 clustered with canid alphaherpesvirus isolated from the UK and shared a 99% overall nucleotide sequence similarity. CONCLUSION: This is the first complete genome of an Australian strain of CHV-1, which will contribute to our understanding of the genetics and evolution of herpesvirus.
Asunto(s)
Enfermedades de los Perros/genética , Enfermedades de los Perros/virología , Infecciones por Herpesviridae/veterinaria , Herpesvirus Cánido 1/genética , Animales , Australia , Autopsia/veterinaria , ADN Viral/genética , Bases de Datos de Ácidos Nucleicos , Perros , Femenino , Infecciones por Herpesviridae/genética , Hígado/virología , Filogenia , Reacción en Cadena de la Polimerasa/veterinariaRESUMEN
BACKGROUND: Chemokines are strong candidate genes for outcome of HCV infection. I-TAC is a chemokine known to be involved in the inflammatory process of HCV infection, and its expression is upregulated in chronic hepatitis C (CHC). OBJECTIVES: The aim of this study was to investigate genetic variability in the I-TAC promoter and to determine the correlation of these variants with HCV disease progression. STUDY DESIGN: I-TAC genotyping was performed in 60 chronic HCV patients and 60 controls using GeneScan analysis. Functional analysis of the I-TAC promoter was performed with the aid of luciferase reporter constructs transfected into Huh-7 cells or Huh-7 cells harbouring HCV genomic and sub-genomic replicons. Cytokine induced production of I-TAC from whole blood cultures was measured using enzyme-linked immunosorbent assay (ELISA). RESULTS: Sequencing of approximately 1 kb upstream of the I-TAC gene start codon revealed the presence of a novel 5 bp deletion mutant (-599del5) in a number of chronic HCV patients. Analysis of the functional potential of this deletion revealed no transcriptional change in Huh-7 cells transfected with luciferase reporter constructs, and this was confirmed in cytokine stimulated whole blood cultures where similar levels of I-TAC were liberated regardless of -599del5 genotype. Conversely, the -599del5 deletion variant significantly reduced transcriptional activity of the I-TAC promoter in the presence of replicating HCV. The distribution frequency of the allele was found to be significantly increased in a chronically HCV infected population compared to healthy controls. CONCLUSIONS: The novel I-TAC -599del5 promoter polymorphism is a functional variant in the presence of replicating HCV. Furthermore, this deletion mutant is significantly increased in a chronic HCV cohort and may predispose to HCV disease susceptibility.
Asunto(s)
Quimiocinas CXC/genética , Quimiocinas CXC/metabolismo , Hepacivirus/fisiología , Polimorfismo Genético , Regiones Promotoras Genéticas , Replicación Viral , Secuencia de Bases , Línea Celular Tumoral , Quimiocina CXCL11 , Quimiocinas CXC/química , Hepacivirus/patogenicidad , Hepatitis C Crónica/virología , Hepatocitos/virología , Humanos , Datos de Secuencia MolecularRESUMEN
BACKGROUND: The influence of immune response gene variations on the development of chronic complications of Q fever is presently unclear. AIM: To compare the frequencies of allelic polymorphisms in immune response genes in different Q fever patient groups. DESIGN: Genetic association study. METHODS: We measured the frequencies of immune response gene variants in: (i) an expanded group of 31 post-Q-fever fatigue patients (QFS); (ii) 22 Q fever endocarditis patients (QFE); and (iii) 22 patients who made an uncomplicated recovery from their initial attack of primary acute Q fever, comparing them with various standard control panels from the general population. RESULTS: There were significant differences between the three Q fever groups. QFS patients differed from both QFE and uncomplicated patients and controls in the frequency of carriage of HLA-DRB1*11 and of the 2/2 genotype of the interferon-gamma intron1 microsatellite. Carriage of the HLA DRB1*11 allele was associated with reduced interferon-gamma and IL-2 responses from PBMC stimulated with ligand in short-term culture. QFE showed differences in the IL-10 promoter microsatellites R and G and had higher frequencies of the TNF-alpha receptor II 196R polymorphism. Q fever patients who had made an uncomplicated recovery differed from those with QFS or QFE, but were not significantly different in allelic frequencies to the control panels. DISCUSSION: These immunogenetic differences support the concept of different immune states in chronic Q fever, determined by genetic variations in host immune responses, rather than by solely properties of Coxiella burnetii.
Asunto(s)
Endocarditis Bacteriana/genética , Síndrome de Fatiga Crónica/genética , Fiebre Q/genética , Coxiella burnetii , Frecuencia de los Genes/genética , Variación Genética , Humanos , Interferón gamma/genética , Polimorfismo Genético , Fiebre Q/complicaciones , Receptores Tipo II del Factor de Necrosis Tumoral/genéticaRESUMEN
By means of a retrospective study with an analysis of the data of 12,743 postmortem examinations over a period of 10 years 630 autopsy cases have been ascertained which had a connection to an insurer. Considerable differences in the reaction and behaviour in the event of damage have been found between public and private insurers. In the course of preliminary investigations by professional/trade associations or pension offices in general an immediate and consistent reaction for this group of insured persons--which has been recorded "purely accidentally"--is to be observed through initiating or analysing of postmortem investigations. Quite in contrast to these findings private insurers to only a small percentage made use of their contractual possibilities of a postmortem control and--if at all--mostly delayed, especially in those cases where the costs of such an investigation were to be debited to the insurer's account. In most cases private insurers made use of the results of postmortems by scientific organisations, courts or professional associations. According to the results of an examination following the rules of forensic medicine of postmortem findings an insurance contract conditions, in more than 50 p. c. of the cases the medical preconditions for the performance of the insurance contract had to be denied. A critical comment should follow: in quite a number of undisclosed cases a regulation of accident and life insurance claims is carried through in which unfounded decisions are taken without any postmortem controls.
Asunto(s)
Autopsia/legislación & jurisprudencia , Causas de Muerte , Seguro por Accidentes/legislación & jurisprudencia , Seguro de Vida/legislación & jurisprudencia , Adulto , Diagnóstico Diferencial , Determinación de la Elegibilidad/legislación & jurisprudencia , Femenino , Humanos , Masculino , Persona de Mediana EdadAsunto(s)
Programas de Inmunización/tendencias , Enfermedades Profesionales/prevención & control , Fiebre Q/prevención & control , Vacunas contra Rickettsia/uso terapéutico , Animales , Humanos , Programas de Inmunización/economía , Programas de Inmunización/legislación & jurisprudencia , Enfermedades Profesionales/economía , Enfermedades Profesionales/epidemiología , Enfermedades Profesionales/inmunología , Fiebre Q/economía , Fiebre Q/epidemiología , Fiebre Q/inmunología , Vacunas contra Rickettsia/economía , Vacunas contra Rickettsia/inmunología , Australia del Sur/epidemiologíaRESUMEN
A majority of the population in industrialized countries does its work while sitting. The necessity of morphologically and physiologically adapting body-supporting systems to the human body cannot be limited to the use of traditional body measurements and certain inclination angles. An investigation of the sitting-pressure distribution is also necessary. The instruments developed for this purpose, the pressure-measuring chair and the sitting pressure simulator, are presented, and their results illustrated by specific examples. As a result of these investigations, sitting-pressure distribution and sitting behaviour have become test-criteria for the suitability of sears, office chairs, etc.
Asunto(s)
Arquitectura y Construcción de Instituciones de Salud , Diseño Interior y Mobiliario , Postura , Presión , Automóviles , Equipos y Suministros , HumanosRESUMEN
Patients who have had successful treatment for either chronic heel pain (plantar fasciitis) or humeral epicondylitis subsequently were evaluated for a comparable problem in the contralateral heel or elbow. Patients who had experienced symptoms in the contralateral heel or elbow for a shorter period were less likely to have a positive result from shock wave therapy than those patients who had received treatments for more chronic symptoms.
Asunto(s)
Fascitis/terapia , Enfermedades del Pie/terapia , Ondas de Choque de Alta Energía/uso terapéutico , Manejo del Dolor , Dolor , Codo de Tenista/terapia , Adulto , Anciano , Fascitis/complicaciones , Femenino , Enfermedades del Pie/complicaciones , Humanos , Masculino , Persona de Mediana Edad , Dolor/etiología , Estudios Retrospectivos , Codo de Tenista/complicaciones , Factores de TiempoRESUMEN
Acute primary Q fever is followed by various chronic sequelae. These include subacute Q fever endocarditis, granulomatous reactions in various organs or a prolonged debilitating post-infection fatigue syndrome (QFS). The causative organism, Coxiella burnetii, persists after an initial infection. The differing chronic outcomes may reflect variations within cytokine and accessory immune control genes which affect regulation of the level of persistence. As a preliminary test of the concept we have genotyped QFS patients and controls for gene variants spanning 15 genes and also examined HLA-B and DR frequencies. QFS patients exhibited a significantly increased frequency of HLA-DR-11 compared with controls and also significant differences in allelic variant frequencies within the NRAMP, and IFNgamma genes. These results indicate a possible genetic role in the expression of overt chronic Q fever. Further studies will be undertaken to increase sample sizes, to survey other forms of chronic Q fever and to examine Q fever patients who have recovered without sequelae.